2023 annual financial data
BriaCell Therapeutics 2023 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -31,080,690 USD and net income was -27,114,354 USD.
Operating cash flow was -31,891,100 USD.
Get free BriaCell Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -31,080,690 USD
- Net income
- -27,114,354 USD
- Operating cash flow
- -31,891,100 USD